Transdermal Bioavailability

Transdermal Bioavailability is the fraction and rate of a drug absorbed through the skin into the systemic circulation following transdermal administration, distinguishing it from other route-dependent bioavailability measures by its specific dependence on dermal permeation kinetics and cutaneous barrier properties.

630

Publications

28.5K

Citations

2.4K

Authors

730

Institutions

Publications per year

2017–2026

161

Authors

2.4K

  1. JH
    Jonathan Hadgraft

    University of Nottingham, United Kingdom

    8 publications · 614 citations

    8

    h-index

  2. VM
    Virginia Merino

    Universitat de València, Spain

    7 publications · 183 citations

    7

    h-index

  3. JM
    Jiradej Manosroi

    Chiang Mai University, Thailand

    6 publications · 297 citations

    6

    h-index

  4. AM
    Aranya Manosroi

    Chiang Mai University, Thailand

    6 publications · 297 citations

    6

    h-index

  5. RH
    Richard H. Guy

    University of California, San Francisco, United States

    6 publications · 1.4K citations

    6

    h-index

1–5 of 2.4K

Venues

  1. International Journal of Pharmaceutics

    68 publications · 3.6K citations

    37

    h-index

  2. Pharmaceutical Research

    20 publications · 1.1K citations

    20

    h-index

  3. Drug Development and Industrial Pharmacy

    30 publications · 1.5K citations

    20

    h-index

  4. Journal of Pharmaceutical Sciences

    25 publications · 1.2K citations

    19

    h-index

  5. European Journal of Pharmaceutics and Biopharmaceutics

    EJPB · 17 publications · 905 citations

    17

    h-index

1–5